It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mycobacterial HelD is a transcription factor that recycles stalled RNAP by dissociating it from nucleic acids and, if present, from the antibiotic rifampicin. The rescued RNAP, however, must disengage from HelD to participate in subsequent rounds of transcription. The mechanism of release is unknown. We show that HelD from Mycobacterium smegmatis forms a complex with RNAP associated with the primary sigma factor σA and transcription factor RbpA but not CarD. We solve several structures of RNAP-σA-RbpA-HelD without and with promoter DNA. These snapshots capture HelD during transcription initiation, describing mechanistic aspects of HelD release from RNAP and its protective effect against rifampicin. Biochemical evidence supports these findings, defines the role of ATP binding and hydrolysis by HelD in the process, and confirms the rifampicin-protective effect of HelD. Collectively, these results show that when HelD is present during transcription initiation, the process is protected from rifampicin until the last possible moment.
This study provides mechanistic insights into how the mycobacterial transcription factor HelD gradually dissociates from RNAP during transcription initiation and protects RNAP from rifampicin until the last possible moment.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Borah, Nabajyoti 2 ; Sudzinová, Petra 3
; Brezovská, Barbora 3 ; Šanderová, Hana 3
; Vaňková Hausnerová, Viola 2 ; Křenková, Alena 4 ; Hubálek, Martin 4 ; Trundová, Mária 1 ; Adámková, Kristýna 1 ; Dušková, Jarmila 1 ; Schwarz, Marek 3
; Wiedermannová, Jana 3
; Dohnálek, Jan 1 ; Krásný, Libor 3
; Kouba, Tomáš 4
1 Institute of Biotechnology of the Czech Academy of Sciences, Vestec, Czech Republic (GRID:grid.448014.d)
2 Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic (GRID:grid.418800.5) (ISNI:0000 0004 0555 4846); Charles University, Department of Genetics and Microbiology, Faculty of Science, Prague, Czech Republic (GRID:grid.4491.8) (ISNI:0000 0004 1937 116X)
3 Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic (GRID:grid.418800.5) (ISNI:0000 0004 0555 4846)
4 Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic (GRID:grid.418892.e) (ISNI:0000 0001 2188 4245)




